References in periodicals archive ?
The experience we gained in our first-in-human study and the subsequent clinical evaluation of our new formulation gives us great confidence as we begin this dose-ranging study.
We are pleased that the first patient in our PASS study and the first patient in our Phase 1 dose-ranging study have been dosed, and look forward to additional patient enrollment in the three ADASUVE studies in the coming months.
For the time being it is evident that Edoxaban is currently the only Factor Xa inhibitor with a dose-ranging study conducted with patients with atrial fibrillation and is, thus, starting with optimal dosing in clinical Phase III.
The dose-ranging study started patients on 20 mg a day and titrated them up to 50 mg a day over 12 weeks based on serum calcium and PTH levels.
SAN FRANCISCO, July 16, 2014 /PRNewswire/ -- Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
The phase 2, double-blind, randomized, placebo-controlled, multi-site, dose-ranging study will enroll 320 patients 18 years of age and older who have elevated hsCRP levels and have been taking statins for at least three months.
Updated clinical and pharmacokinetic (PK) data on tesetaxel, the leading oral taxane in clinical development, will be presented from a dose-ranging study using a once every 3-weeks schedule.
NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunction were presented at the American Psychiatric Association (APA) 2014 Annual Meeting in New York, NY on Tuesday, May 6, 2014 at 2:30 PM ET.
Study 0603 was a Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study which enrolled 85 patients at five centers in the United Kingdom, Canada, and Australia.
NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunction were presented at the American College of Obstetricians and Gynecologists (ACOG) 2014 Annual Clinical Meeting in Chicago, IL on Monday, April 28, 2014 at 3:45 PM local time.
The ILY101 Phase 2 trial is a multi-center, randomized, dose-ranging study of 120 patients.
NASDAQ: PETX), a biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, today announced positive results from its dose-ranging study of AT-001, the company's innovative drug for treating pain in dogs with osteoarthritis.